Biotech Stock Roundup: ALXN Soliris Successful, Respite For Sarepta, AMRN Soars
Key highlights in this week include Alexion’s ALXN efforts to expand lead drug Soliris label gets a boost while Gilead Sciences GILD looks to launch generics for HCV drugs. On the other hand, a mixed week for Sarepta Therapeutics SRPT . […]